JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 5, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/10/8966    most recent
M303976200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kahlig, K. M.
Right arrow Articles by Galli, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kahlig, K. M.
Right arrow Articles by Galli, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print December 29, 2003
J. Biol. Chem, 10.1074/jbc.M303976200
Submitted on April 15, 2003
Revised on December 11, 2003
Accepted on December 22, 2003

Amphetamine regulation of dopamine transport: Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier

Kristopher M. Kahlig, Jonathan A. Javitch, and Aurelio Galli

Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232

Corresponding Author: Aurelio.Galli{at}Vanderbilt.edu

Dopaminergic neurotransmission is fine-tuned by rate of removal of dopamine (DA) from the extracellular space via the Na+/Cl- dependent DA transporter (DAT). DAT is a target of psychostimulants such as amphetamine (AMPH) and cocaine. Previously, we reported that AMPH redistributes the human DAT away from the cell surface. This process was associated with a reduction in transport capacity. This loss of transport capacity may result either from a modification of DAT’s function that is independent of its cell surface redistribution and/or from a reduction in the number of active transporters at the plasma membrane that results from DAT trafficking. To discriminate between these possibilities, we stably transfected HEK-293 cells with a yellow fluorescent protein (YFP) tagged human DAT (hDAT cells). In hDAT cells, acute exposure to AMPH induced a time-dependent loss of hDAT activity. By coupling confocal imaging with patch-clamp whole recordings, we have demonstrated for the first time that the loss of AMPH-induced hDAT activity temporally parallels the accumulation of intracellular hDAT. In addition, presteady-state current analysis revealed a cocaine sensitive, voltage-dependent capacitance current that correlated with the level of transporter membrane expression and in turn served to monitor the AMPH-induced trafficking of hDAT. We found that the decrease in hDAT cell surface expression induced by AMPH was not paralleled by changes in the ability of the single transporter to carry charges. Quasi-stationary noise analysis of the AMPH-induced hDAT currents revealed that the unitary transporter current remained unaltered during the loss of hDAT membrane expression. Taken together, these data strongly suggest that the AMPH reduction of hDAT transport capacity results from the removal of active hDAT from the plasma membrane.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Kahlig, T. H. Rhodes, M. Pusch, T. Freilinger, J. M. Pereira-Monteiro, M. D. Ferrari, A. M. J. M. van den Maagdenberg, M. Dichgans, and A. L. George Jr.
Divergent sodium channel defects in familial hemiplegic migraine
PNAS, July 15, 2008; 105(28): 9799 - 9804.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Erreger, C. Grewer, J. A. Javitch, and A. Galli
Currents in Response to Rapid Concentration Jumps of Amphetamine Uncover Novel Aspects of Human Dopamine Transporter Function
J. Neurosci., January 23, 2008; 28(4): 976 - 989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Zapata, B. Kivell, Y. Han, J. A. Javitch, E. A. Bolan, D. Kuraguntla, V. Jaligam, M. Oz, L. D. Jayanthi, D. J. Samuvel, et al.
Regulation of Dopamine Transporter Function and Cell Surface Expression by D3 Dopamine Receptors
J. Biol. Chem., December 7, 2007; 282(49): 35842 - 35854.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Wei, J. M. Williams, C. Dipace, U. Sung, J. A. Javitch, A. Galli, and C. Saunders
Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism
Mol. Pharmacol., March 1, 2007; 71(3): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli
Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes
Mol. Pharmacol., January 1, 2007; 71(1): 230 - 239.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. M. Kahlig, B. J. Lute, Y. Wei, C. J. Loland, U. Gether, J. A. Javitch, and A. Galli
Regulation of Dopamine Transporter Trafficking by Intracellular Amphetamine
Mol. Pharmacol., August 1, 2006; 70(2): 542 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Cervinski, J. D. Foster, and R. A. Vaughan
Psychoactive Substrates Stimulate Dopamine Transporter Phosphorylation and Down-regulation by Cocaine-sensitive and Protein Kinase C-dependent Mechanisms
J. Biol. Chem., December 9, 2005; 280(49): 40442 - 40449.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. G. Garcia, Y. Wei, J. A. Moron, R. Z. Lin, J. A. Javitch, and A. Galli
Akt Is Essential for Insulin Modulation of Amphetamine-Induced Human Dopamine Transporter Cell-Surface Redistribution
Mol. Pharmacol., July 1, 2005; 68(1): 102 - 109.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Kahlig, F. Binda, H. Khoshbouei, R. D. Blakely, D. G. McMahon, J. A. Javitch, and A. Galli
Amphetamine induces dopamine efflux through a dopamine transporter channel
PNAS, March 1, 2005; 102(9): 3495 - 3500.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Kantor, M. Zhang, B. Guptaroy, Y. H. Park, and M. E. Gnegy
Repeated Amphetamine Couples Norepinephrine Transporter and Calcium Channel Activities in PC12 Cells
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1044 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Gnegy, H. Khoshbouei, K. A. Berg, J. A. Javitch, W. P. Clarke, M. Zhang, and A. Galli
Intracellular Ca2+ Regulates Amphetamine-Induced Dopamine Efflux and Currents Mediated by the Human Dopamine Transporter
Mol. Pharmacol., July 1, 2004; 66(1): 137 - 143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.